ReviewNature reviews. Drug discovery2023
Targeting HER2-positive breast cancer: advances and future directions.
Sandra M Swain et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
671 papers cite itlatest 60 shown
this paperpooled ittrialcites it